Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E.

Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 11/2007; 104(47):18666-70. DOI: 10.1073/pnas.0708423104
Source: PubMed

ABSTRACT Hepatitis C virus (HCV) is a single-stranded positive-sense RNA virus of the Flaviviridae family. HCV-infected hepatocytes are known to produce reactive oxygen species (ROS), which initiate lipid peroxidation, a reaction that converts polyunsaturated fatty acids, such as arachidonate, into reactive carbonyls that inactivate proteins. To study the effect of lipid peroxidation on HCV replication, we administered arachidonate to Huh7 cells that harbor an HCV replicon (Huh7-K2040 cells). After incubation in medium supplemented with arachidonate but deprived of lipid-soluble antioxidants, the cellular amount of malondialdehyde (MDA), a product of lipid peroxidation, increased markedly in Huh7-K2040 cells but not in parental Huh7 cells that do not harbor an HCV replicon. This increase was followed by a sharp reduction (>95%) in HCV RNA. Both of these events were prevented when cells were treated with vitamin E, a lipid-soluble antioxidant. After prolonged incubation of Huh7-K2040 cells with arachidonate in the absence of lipid-soluble antioxidants, the amount of MDA decreased after the reduction in the amount of HCV RNA. Thus, in the presence of arachidonate and in the absence of lipid-soluble antioxidants, HCV replication induces lipid peroxidation that reduces the amount of HCV RNA. Our results provide a mechanism for the previous observation that polyunsaturated fatty acids inhibit HCV replication [Kapadia SB, Chisari FV (2005) Proc Natl Acad Sci USA 102:2561-2566], and they suggest that these agents may be effective in inhibiting HCV replication in vivo.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Many viruses, including hepatitis C virus (HCV), induce changes to the infected host cell metabolism that include the upregulation of lipogenesis to facilitate viral propagation. Acetyl-CoA carboxylase (ACC) polymerizes to form a supramolecular complex that catalyzes the rate-limiting step of de novo lipogenesis. Soraphen A (SorA) acts as a nanomolar inhibitor of ACC activity through disruption of the formation of highly active ACC polymers from less active dimers. We have shown that SorA inhibits HCV replication in HCV cell culture models expressing replicons (IC50=5 nM) or infected with virus. Using coherent anti-Stokes Raman scattering microscopy, we have demonstrated that SorA lowers cellular lipid levels in hepatoma cells, consistent with decreased de novo lipogenesis. Furthermore, native PAGE analysis confirmed SorA induced depolymerized of ACC complexes into less active dimers. Our results demonstrate that SorA is a valuable probe to study the roles of ACC polymerization and enzymatic activity in viral pathogenesis.
    02/2015; DOI:10.1021/acsinfecdis.5b00019
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C Virus (HCV) infects over 150 million people worldwide. In most cases HCV infection becomes chronic, causing liver disease ranging from fibrosis to cirrhosis and hepatocellular carcinoma. HCV affects the cholesterol homeostasis and at the molecular level, every step of the virus life cycle is intimately connected to lipid metabolism. In this review, we present an update on the lipids and apolipoproteins that are involved in the HCV infectious cycle steps: entry, replication and assembly. Moreover, the result of the assembly process is a lipoviroparticle, which represents a peculiarity of hepatitis C virion. This review illustrates an example of an intricate virus-host interaction governed by lipid metabolism.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative tissue injury often accompanies viral infection, yet there is little understanding of how it influences virus replication. We show that multiple hepatitis C virus (HCV) genotypes are exquisitely sensitive to oxidative membrane damage, a property distinguishing them from other pathogenic RNA viruses. Lipid peroxidation, regulated in part through sphingosine kinase-2, severely restricts HCV replication in Huh-7 cells and primary human hepatoblasts. Endogenous oxidative membrane damage lowers the 50% effective concentration of direct-acting antivirals in vitro, suggesting critical regulation of the conformation of the NS3-4A protease and the NS5B polymerase, membrane-bound HCV replicase components. Resistance to lipid peroxidation maps genetically to transmembrane and membrane-proximal residues within these proteins and is essential for robust replication in cell culture, as exemplified by the atypical JFH1 strain of HCV. Thus, the typical, wild-type HCV replicase is uniquely regulated by lipid peroxidation, providing a mechanism for attenuating replication in stressed tissue and possibly facilitating long-term viral persistence. This article is protected by copyright. All rights reserved. © 2014 by the American Association for the Study of Liver Diseases.
    Hepatology 03/2015; 61(3). DOI:10.1002/hep.27637 · 11.19 Impact Factor

Full-text (2 Sources)

Available from
Nov 6, 2014